H.U. Group Holdings, Inc.

Holding Companies & Conglomerates · Japan · 5K - 10K Employees

View Company Info for Free

Overview

Headquarters

2-1-1 Nishisinjuku Fl 8, Tokyo, Tokyo, 1...

Phone Number

+81 359093335

Website

www.hugp.com

Revenue

$1.6 Billion

Industry

Holding Companies & Conglomerates

Manufacturing

Pharmaceuticals

Healthcare Services

Medical Laboratories & Imaging Centers

ZI Rank: 7

Signal Type

Dec

Jan

Feb

Mar

Apr

May

ZI Rank

H.U. Group Holdings, Inc.’s Company Summary

H.U. Group Holdings, Inc., established in 2017, is a prominent Japanese holding company operating within the healthcare sector. With a substantial annual revenue of $1.6B, the company focuses on the manufacture and sale of clinical test drugs, entrusted clinical examination services, and sterilization-related businesses. Headquartered in Tokyo, Japan, H.U. Group Holdings Inc. (formerly Miraca Holdings Inc.) plays a critical role in advancing public health through its diagnostic and medical solutions. Its strategic operations are geared towards providing essential healthcare products and services, including diagnostics, medical care, and public health initiatives, serving both B2B and B2C markets.

The company operates with a significant workforce, ranging from 5,000-10,000 employees, and maintains a singular primary location. This scale of operation supports its comprehensive product portfolio, which includes vital items such as antigen and PCR tests, alongside broader healthcare and clinical testing services. For insights into the dedicated professionals driving these efforts, one can Meet H.U. Group Holdings, Inc.'s team to understand the organizational expertise. The company's commitment extends to ensuring the availability of critical medical supplies and diagnostic tools, underpinning its position in the healthcare ecosystem.

Leveraging its founding year of 2017, H.U. Group Holdings, Inc. has built a reputation for reliability in the healthcare industry. Its product offerings are diverse, encompassing everything from specific tests like antigen and PCR to broader categories such as clinical testing and medical care. The company's strategic focus on innovation and quality in diagnostics and related services positions it as a key player in Japan's healthcare landscape. Hashtags likeView more...

AI for GTM

The summary is generated by AI and may contain inaccuracies. Verify critical information with official sources.

About H.U. Group Holdings, Inc.

H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company. It engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The company is headquartered in Tokyo, Japan.Explore more

Is this data correct?

View contact profiles from H.U. Group Holdings, Inc.

Popular SearchesHU GroupHU Group Holdings IncHU Groups Holdings IncHU Frontier IncHU Group Holdings (HU)SIC Code 67,671NAICS Code 55,551Ticker MRCHFShow more

H.U. Group Holdings, Inc. Org Chart

Shigekazu Takeuchi

Chairman & Chief Executive Officer

Phone

Naoki Kitamura

Managing Executive Officer and Chief Financia...

Phone

Get the full picture

Miyako Izumi

Manager, Purchasing

Phone

Get the full picture

Is H.U. Group Holdings, Inc. your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if H.U. Group Holdings, Inc. has recently received funding, and reach out quickly before it becomes old news!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Funding: Get notified immidiatlly once H.U. Group Holdings, Inc. has new funding data

Product Launch: Get notified when H.U. Group Holdings, Inc. launches new products

Website visits: Recent activity has been detected on your website

H.U. Group Holdings, Inc., which may be a good buyer, showed buying intent in Masked Content Topic

Click to see if H.U. Group Holdings, Inc. had a recent Job posting/layoffs

Congratulate Masked Content for being promoted to Masked Content at H.U. Group Holdings, Inc.

Earning: See what the market has to say on H.U. Group Holdings, Inc. recently announced quarterly report

Check out if H.U. Group Holdings, Inc. is spiking on competitors!

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 2 more new buyers

View Email Formats for H.U. Group Holdings, Inc.

Among all Holding Companies & Conglomerates companies

Low Activity

High Activity

Activity Insights

H.U. Group Holdings, Inc. is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.

What does this means?

H.U. Group Holdings, Inc. is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about H.U. Group Holdings, Inc..

H.U. Group Holdings, Inc. Tech Stack

A closer look at the technologies used by H.U. Group Holdings, Inc.

See more technologies

H.U. Group Holdings, Inc. News & Media

Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
TOKYO, Dec 23, 2024 - (JCN Newswire) - Fujirebio Holdings, Inc., a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., Ltd. announced today that they have entered into a memorandum of understanding for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases. Fujirebio and Eisai have been conducting joint research on cerebrospinal fluid biomarkers related to Alzheimer’s disease (AD). The two companies have agreed to
www.jcnnewswire.com
Fujirebio Diagnostics Lumipulse® G β-Amyloid Ratio (1-42/1-40) In Vitro Diagnostic Test Receives Marketing Authorization for the Assessment of Alzheimer’s Disease
MALVERN, Pa.--(BUSINESS WIRE)-- #Alzheimers--Fujirebio says the FDA has granted De Novo marketing authorization for the firm’s Lumipulse Amyloid Ratio in vitro diagnostic test for Alzheimer’s.
www.businesswire.com

Top Holding Companies & Conglomerates Companies

Frequently Asked Questions Regarding H.U. Group Holdings, Inc.

What is H.U. Group Holdings, Inc.'s official website?

H.U. Group Holdings, Inc.'s official website is www.hugp.com

What is H.U. Group Holdings, Inc.'s Revenue?

H.U. Group Holdings, Inc.'s revenue is $1.6 Billion

What is H.U. Group Holdings, Inc.'s SIC code?

H.U. Group Holdings, Inc.'s SIC: 67,671

What is H.U. Group Holdings, Inc.'s NAICS code?

H.U. Group Holdings, Inc.'s NAICS: 55,551

How many employees does H.U. Group Holdings, Inc. have?

H.U. Group Holdings, Inc. has 5K - 10K employees

What industry does H.U. Group Holdings, Inc. belong to?

H.U. Group Holdings, Inc. is in the industry of: Holding Companies & Conglomerates, Manufacturing, Pharmaceuticals

What companies has H.U. Group Holdings, Inc. acquired?

H.U. Group Holdings, Inc. has acquired the companies: American Biological Technologies, CanAg Diagnostics, Innogenetics, ADx NeuroSciences

What technology does H.U. Group Holdings, Inc. use?

Some of the popular technologies that H.U. Group Holdings, Inc. uses are: DocuSign, Google Custom Search, Google AdSense, DoubleClick

Who is the CFO of H.U. Group Holdings, Inc.?

H.U. Group Holdings, Inc.'s CFO is Naoki Kitamura

How do I contact H.U. Group Holdings, Inc.?

H.U. Group Holdings, Inc. contact info: Phone number: +81 359093335 Website: www.hugp.com

What does H.U. Group Holdings, Inc. do?

What are H.U. Group Holdings, Inc. social media links?

H.U. Group Holdings, Inc. Linkedin page

See more information about H.U. Group Holdings, Inc.

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.